Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice